青岛英派斯健康科技股份有限公司 2024年年度股东大会决议公告

Meeting Overview - The shareholder meeting was held on May 20, 2025, at 14:30 [3] - The meeting combined both on-site and online voting methods [6] - The meeting was chaired by the company's chairman, Liu Hongtao [8] Attendance - A total of 102 shareholders and authorized representatives attended, representing 45,082,700 shares, which is 30.7647% of the company's total voting rights [9] - 2 shareholders attended the meeting in person, representing 40,662,100 shares (27.7481% of voting rights) [9] - 100 shareholders participated via online voting, representing 4,420,600 shares (3.0166% of voting rights) [10] Proposal Voting Results - The following proposals were approved with significant majority votes: - 2024 Board of Directors Work Report: 99.1167% in favor [12] - 2024 Supervisory Board Work Report: 99.1216% in favor [13] - 2024 Annual Report: 99.1167% in favor [14] - 2024 Financial Settlement Report: 99.0739% in favor [15] - 2024 Profit Distribution Plan: 99.1167% in favor, with 90.9924% support from minority investors [16] - Appointment of 2025 Audit Firm: 99.1123% in favor, with 90.9471% support from minority investors [17] - Three-Year Dividend Return Plan (2025-2027): 99.1181% in favor, with 91.0059% support from minority investors [18] - Authorization for Small-Scale Financing: 99.1034% in favor, with 90.8567% support from minority investors [19] Legal Opinion - The legal opinion from Beijing Deheheng Law Firm confirmed that the meeting's procedures, qualifications of attendees, and voting results complied with relevant laws and regulations [19]